Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Sage Therapeutics Inc’s stock clocked out at $13.94, up 6.37% from its previous closing price of $13.10. In other words, the price has increased by $6.37 from its previous closing price. On the day, 0.9 million shares were traded. SAGE stock price reached its highest trading level at $13.97 during the session, while it also had its lowest trading level at $13.45.
Ratios:
To gain a deeper understanding of SAGE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.22 and its Current Ratio is at 12.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 17, 2024, Downgraded its rating to Underperform and sets its target price to $14 from $24 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 09 ’23 when Barrett Elizabeth bought 2,000 shares for $18.64 per share. The transaction valued at 37,279 led to the insider holds 3,000 shares of the business.
Barrett Elizabeth bought 1,000 shares of SAGE for $50,500 on May 09 ’23. The Director now owns 1,000 shares after completing the transaction at $50.50 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAGE now has a Market Capitalization of 838937024 and an Enterprise Value of 125230512. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.21 while its Price-to-Book (P/B) ratio in mrq is 1.19. Its current Enterprise Value per Revenue stands at 1.375 whereas that against EBITDA is -0.247.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $59.99, while it has fallen to a 52-week low of $10.92. The 50-Day Moving Average of the stock is -22.21%, while the 200-Day Moving Average is calculated to be -35.40%.
Shares Statistics:
It appears that SAGE traded 1.07M shares on average per day over the past three months and 1236840 shares per day over the past ten days. A total of 60.04M shares are outstanding, with a floating share count of 49.11M. Insiders hold about 18.39% of the company’s shares, while institutions hold 93.04% stake in the company. Shares short for SAGE as of 1713139200 were 9310631 with a Short Ratio of 8.73, compared to 1710460800 on 8399721. Therefore, it implies a Short% of Shares Outstanding of 9310631 and a Short% of Float of 17.57.
